Comparison

Evodenoson European Partner

Item no. TMO-T31731-500mg
Manufacturer TargetMol
CASRN 844873-47-8
Amount 500 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C23H29N7O6
Smiles O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=C(C#CCC4CCN(C(OC)=O)CC4)N3)O[C@H](C(NC5CC5)=O)[C@H]1O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias DE 112,DE-112,ATL 313,DE112,ATL313,ATL-313
Shipping Condition Cool pack
Available
Manufacturer - Targets
Adenosine Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
499.52
Description
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
Pathways
GPCR/G Protein|||Neuroscience
Bioactivity
Evodenoson( ATL313 and DE-112) is an effective and selective A(2A)AR agonist (A2A adenosine receptor agonist) in development for a novel treatment for sepsis.ATL313 can reduce inflammation and promotes survival in murine sepsis models.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close